Helius Therapeutics, the country’s only vertically integrated medicinal cannabis company, has signed its first export deals to Denmark and Australia in the wake of legislative changes.
In the first major changes since the Medicinal Cannabis Scheme (MCS) came into effect in April 2020, exports now
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
